Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674717018 | Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3674718011 | Dimeticone (as simeticone) 125 mg and loperamide hydrochloride 2 mg chewable tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3674719015 | Dimethicone (as simethicone) 125 mg and loperamide hydrochloride 2 mg chewable tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4611601000052117 | dimetikon (som simetikon) 125 milligram och loperamidhydroklorid 2 milligram, tuggtablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Is a | Loperamide hydrochloride+simethicone | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has active ingredient | Loperamide (substance) | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has active ingredient | Loperamide hydrochloride | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has active ingredient | Simeticone | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Is a | Product containing loperamide and simeticone (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has active ingredient | Loperamide (substance) | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has manufactured dose form | Chewable tablet | true | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Is a | Loperamide-containing product in oral dose form | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | har täljarvärde som visar styrka | 2 (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has precise active ingredient | Simeticone | false | Inferred relationship | Some | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | har täljarvärde som visar styrka | 125 (qualifier value) | false | Inferred relationship | Some | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has precise active ingredient | Loperamide hydrochloride | false | Inferred relationship | Some | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has basis of strength substance (attribute) | Loperamide hydrochloride | false | Inferred relationship | Some | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has basis of strength substance (attribute) | Dimeticone (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Is a | Product containing loperamide and simeticone in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | räkning av bas i aktiv ingrediens | 2 (qualifier value) | false | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Is a | Loperamide and simeticone only product in oral dose form | true | Inferred relationship | Some | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has precise active ingredient | Loperamide hydrochloride | true | Inferred relationship | Some | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has basis of strength substance (attribute) | Loperamide hydrochloride | true | Inferred relationship | Some | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has basis of strength substance (attribute) | Dimeticone (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Has precise active ingredient | Simeticone | true | Inferred relationship | Some | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | Is a | Simeticone-containing product in oral dose form | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets